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Abstract Entry of Shigella flexneri into epithelial cells and lysis 
of the phagosome involve the secreted IpaA-D proteins. A 
complex containing IpaC and IpaB is able to promote uptake of 
inert particles by epithelial cells. This suggested that Ipa 
proteins, either individually or as a complex, might interact with 
the cell membrane. We have purified IpaC and demonstrated its 
interaction with lipid vesicles. This interaction is modulated by 
the pH, which might be relevant to the dual role of Ipa proteins, 
in induction of membrane ruffles upon entry and lysis of the 
endosome membrane thereafter. 
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1. Introduction 
Bacteria of the genus Shigella are the causative agents of 
shigellosis, or bacillary dysentery, an infection confined to 
humans and primates. The early step of infection is the inva-
sion of epithelial cells of the colon. The mechanism of entry of 
Shigella into cells has been studied extensively on cultured cell 
lines. Contact of bacteria with the cell surface induces massive 
rearrangements of the cytoskeleton and local ruffles through 
which bacteria are internalized. Within a few minutes after 
entry, Shigella lyse the membrane of the endosome and gain 
access to the cytoplasmic compartment. Actin polymerization 
and bundling of actin filaments at one pole of dividing bac-
teria allow Shigella to occupy the entire cytoplasm of the 
infected cell and to disseminate from cell to cell (for a review, 
see [1]). 
Genes required for entry and dissemination are carried by a 
200-kb virulence plasmid. A 30-kb fragment of this plasmid is 
necessary and sufficient for entry into cultured cells [2]. This 
fragment is composed of two regions: one of which encodes 
secreted proteins, the IpaA-D proteins, and the other their 
dedicated secretion apparatus, the Mxi-Spa translocon [3-6]. 
Although ipa, mxi, and spa genes are expressed by bacteria 
growing in laboratory media, only a small proportion of Ipa 
proteins is actually secreted by the wild-type strain under 
these growth conditions. In contrast, secretion of presynthe-
sized Ipa proteins is activated upon contact of bacteria with 
epithelial cells, which probably allows Shigella to deliver a 
high concentration of effector molecules in the vicinity of 
the target cell [7]. 
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Characterization of ipa A, ipaB, ipaC and ipaD mutants in-
dicated that each of the Ipa proteins, except IpaA, was re-
quired for entry into epithelial cells. Within the bacterial cy-
toplasm, IpaB and IpaC are independently bound to the same 
molecular chaperone, IpgC, which is encoded by the ipa op-
eron [8]. In contrast, a protein complex containing IpaB, 
IpaC, probably IpaA, but not IpaD has been detected in 
the extracellular medium [8]. Latex beads coated with anti-
IpaC antibodies have been used to recover this complex and 
were shown to be internalized by HeLa cells through forma-
tion of membrane ruffles similar to those induced upon entry 
of Shigella [9]. These results, i.e. the ability of the ipaA mutant 
to enter into epithelial cells and the absence of IpaD in the 
extracellular complex which was able to promote internaliza-
tion of inert particles, have led to the proposal that IpaB and 
IpaC play a major role in entry of Shigella into epithelial cells 
[9]. However, little is known concerning the stoichiometry of 
Ipa proteins within the extracellular complex and their inter-
actions with the cell surface. 
Association of bacterial toxins in a complex is a feature 
characteristic of the so-called Ά - Β ' type toxins. The A and 
B moieties of diphtheria toxin are held together by a disulfide 
bridge whereas those of anthrax toxins exist as independent 
entities in the extracellular medium. In these toxins, the B 
moiety binds to cell surface receptors, interacts with a cellular 
membrane (either the plasma membrane or the membrane of 
the endosome), and mediates the interaction of the A moiety 
with the target membrane. Information on the molecular 
mechanism of interaction of these toxins with cellular mem-
brane has been obtained by characterizing the ability of both 
the individual components and the complex to interact with 
lipid membranes. In vitro studies have shown that the A frag-
ment of diphtheria and anthrax toxins may play an active role 
in protein translocation [10,11]. 
The ipaB, ipaC, and ipaD mutants are not only unable to 
enter into epithelial cells [12], but also to lyse the membrane 
of the phagocytic vacuole when they are internalized by 
macrophages [13] and to induce hemolysis when they are in 
close contact with red blood cells [12]. This suggested that the 
Ipa proteins, either independently or as a complex, might 
interact with and destabilize the cell membrane. Therefore, 
to investigate the possible interaction of Ipa proteins with 
the cell membrane, we have undertaken the purification of 
each of these and the study of their interaction with lipid 
membranes in vitro. Here, we report the purification of 
IpaC and the characterization of its ability to induce the re-
lease of a fluorescent probe encapsulated into large unilamel-
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lar vesicles. We present evidence that IpaC is able to interact 
with lipid vesicles and that this interaction is dependent on the 
p H of the vesicle suspension and on the presence of negatively 
charged lipids in the membrane of vesicles. 
2. Material and methods 
2.1. Bacterial strains and growth media 
The S. flexneri strains used in this study are derivatives of the wild-
type strain M90T (serotype 5). Strain SF620 carries a non-polar mu-
tation in the ipaB gene [12]. The sepA gene of SF620 was inactivated 
by integration of the suicide plasmid pZK12 as previously described 
[14]. The ipaB sepA mutant thus constructed was designated SF6200. 
Bacteria were grown in tryptic soy broth (TCS) containing kanamycin 
(50 μ§/piι1). 
2.2. Materials 
Asolectin (mixed soybean phospholipids), L-a-phosphatidylcholine 
from egg yolk (egg PC), L-oc-phosphatidylserine from bovine brain 
(PS) and calcein were obtained from Sigma (St. Louis, MO). Calcein 
was purified by gel filtration chromatography on Sephadex LH-20 
(Pharmacia, Uppsala, Sweden) as previously described [15]. Asolectin 
was purified according to [16]. The mono-Q column as well as the 
G50 resin used for IpaC purification were purchased from Pharmacia 
(Uppsala, Sweden). The monoclonal antibody J22 directed against 
IpaC was a kind gift of Dr. Armelle Phalipon (Institut Pasteur, Paris, 
France). Urea, Tris, and NaCl were of HPLC grade. All other re-
agents were of analytical grade. 
2.3. IpaC purification 
Strain SF6200 was grown at 37°C for 7 h with agitation and bac-
teria were harvested by centrifugation at lOOOOXg for 30 min (Sorvall 
RC26-PLUS). The culture supernatant was filtered through 0.22 μηι 
filters and proteins were precipitated by addition of ammonium sul-
fate 45% (w/v). After incubation at 4°C for 16 h, the sample was 
centrifuged at lOOOOXg for 30 min and the pellet was resuspended 
in a buffer containing 4 M urea and 5 mM Tris, pH 9.0. The excess of 
ammonium sulfate was removed by chromatography over a G50 col-
umn (40 cm length, 2.6 cm diameter) using the same buffer. The 
protein sample was then loaded on a Mono-Q column (anion ex-
change) equilibrated with the Tris-urea buffer, pH 9.0, and was eluted 
by an NaCl 0-15% gradient (with buffer A containing 4 M urea, 5 
mM Tris, pH 9.0, and buffer B containing 4 M urea, 1 M NaCl, 5 
mM Tris, pH 9.0) using a flow of 1 ml/min. Fractions of the chro-
matography were analyzed by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) according to [17] and either stained 
with Coomassie Blue or transferred onto a nitrocellulose membrane 
and probed with the anti-IpaC J22 mAb [18]. Purity of the protein 
was assessed by sequencing the band corresponding to IpaC after 
transfer onto a polyvinylidenefluoride (PVDF) membrane. The pro-
tein N-terminal sequence was determined on the membrane by auto-
mated Edman degradation using a Beckman LF 3400 D protein 
microsequencer (Dr. R. Wattiez, Universite de l'Etat a Mons, Bel-
gium). 
2.4. Fluorescence measurements 
Fluorescence spectra were recorded on a SLM 8000 fluorimeter 
operating in the ratio mode with excitation and emission slits of 
4 nm. An internal correction was made for changes in lamp intensity 
by using a reference solution of 3 mg/ml of rhodamine B in ethylene 
glycol. During measurement, samples were under constant magnetic 
stirring and the temperature within the 1 cm path-length quartz cu-
vette was maintained at 37 ± 0.5°C. 
2.5. Calcein release assay 
Large unilamellar vesicles (LUV) containing 90 mM calcein were 
prepared in 10 mM Hepes, pH 7.2, according to the procedure of [19] 
by using an extruder (Lipex Biomembranes Inc., Vancouver, Canada). 
The non-encapsulated dye was removed from the liposome suspension 
by chromatography on a Sephadex G-50 column equilibrated with 10 
mM Hepes, 150 mM NaCl, and 1 mM EDTA, pH 7.2. The liposome 
concentration was determined by measuring the lipid phosphorus con-
tent as previously described [20], The osmolarity of the solution (cal-
cein and buffer) was measured with a Roebling osmometer and fixed 
to 310 ±5 mosmol/kg of water. 
Fluorescence of calcein, which is entrapped in unilamellar vesicles 
at a self-quenching concentration, is increased after release of calcein 
from liposomes. The IpaC-induced release of calcein was recorded by 
measuring the fluorescence of the liposome suspension at excitation 
and emission wavelengths of 490 and 520 nm, respectively. Complete 
release of the dye was obtained by lysing the LUV with Triton X-100 
at a final concentration of 0.1%. The percentage of fluorescence F(t) 
at time t is defined as: 
where I0 is the initial fluorescence obtained after dilution of the ves-
icles in the appropriate buffer, I; is the total fluorescence observed 
after addition of Triton X-100 and I(t) is the fluorescence at time t 
corrected for the dilution. An aliquot of the LUV suspension (between 
5 and 12.5 μΐ) containing the dye (pH 7.2) was added to the fluo-
rescent cuvette containing the buffer at the chosen pH (total volume 
of 1 ml). After pH and temperature equilibration, the protein was 
added to the suspension and the fluorescence was immediately meas-
ured. Buffers used for the different pH were as follows: 10 mM Hepes, 
150 mM NaCl, 1 mM EDTA, pH 7.2; 10 mM Mes, 150 mM NaCl, 
1 mM EDTA, pH 6.5-6.0; and 10 mM acetate, 150 mM NaCl, 1 mM 
EDTA, pH 5.0-5.4. 
3. Results 
3.1. Purification of IpaC 
IpaC was purified from the culture medium of the S. flex-
neri strain SF6200 in which both the ipaB and sepA genes 
have been inactivated. This strain was chosen for the follow-
ing reasons: (1) during growth in laboratory media, an ipaB 
mutant secretes IpaC in greater amounts as compared to the 
wild-type strain, in which Ipa secretion is regulated by contact 
with the target cell; (2) part of IpaB and IpaC are present in a 
complex in the extracellular medium of the wild-type strain. 
Purification of IpaC from a strain devoid of IpaB eliminated 
the possibility of contamination with IpaB; and (3) in prelim-
inary attempts to purify IpaC from the culture medium of 
the ipaB mutan t SF620, we observed that SepA, a major ex-
tracellular protein of S. flexneri [14], was eluted from the 
anion exchange chromatography column at the same salt con-
centration as IpaC and was the only contaminating protein 
found in fractions containing IpaC (data not shown). This led 
us to construct strain SF6200 by inactivating the sepA gene in 
the iapB mutan t SF620 (see Section 2). 
Starting from the culture medium of strain SF6200, the 
main steps in purification of IpaC were an ammonium sulfate 
precipitation followed by an anion exchange chromatography 
using a Tris buffer, p H 9.0, containing 4 M urea. The p H of 
the buffer was chosen by taking into account the high iso-
electric point of IpaC (pi = 8.96). In the absence of urea, 
IpaC was found in many fractions (data not shown), probably 
because of non-specific interactions with other secreted pro-
teins, which greatly reduced the yield of purification of IpaC. 
In the presence of 4 M urea, IpaC was eluted from the anion 
exchange chromatography at a salt concentration of 140 m M 
NaCl (Fig. 1), as indicated by SDS-PAGE analysis of frac-
tions of the chromatogram (see inset in Fig. 1). The 40-kDa 
protein present in fraction 22 was identified as the IpaC pro-
tein (41 kDa) on the following criteria: after electrophoresis 
and transfer onto a membrane, this protein was strongly rec-
ognized by the J22 monoclonal antibody directed against 
IpaC [18] (data not shown), and its N-terminal sequence 
was determined as M e t - G l u - I l e - G l n - A s n - T h r - L y s - P r o -
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Fig. 1. Purification of IpaC. The elution profile of a representative run on the Mono-Q column is shown, with the absorbance at 280 nm indi-
cated by a continuous line and the salt gradient profile indicated by a dashed line (100%= 1 M NaCl). The SDS-PAGE analysis of fractions of 
the chromatogram containing IpaC is shown in the inset. Numbers of fractions are indicated on the chromatogram. 
Thr-Gln-Thr-Leu-Tyr-Thr-Asp, which corresponds to that 
of IpaC. No other sequence was detectable in that band, 
which, in addition to the analysis of that fraction by SDS-
PAGE and Coomassie Blue staining, indicated that IpaC has 
been purified with a degree of purity to over 90%. Moreover, 
no degradation seemed to occur during purification. 
3.2. Interaction of IpaC with the lipid membrane as a function 
ofpH 
To investigate the possible interaction of IpaC with a lipid 
membrane, we studied the ability of the purified protein to 
induce the release of a fluorescent probe encapsulated into 
large unilamellar vesicles. Since interaction of some bacterial 
toxins with a lipid membrane is strongly pH-dependent, we 
have investigated the effect of pH on the release of calcein 
induced by IpaC. 
The kinetics of calcein release after addition of IpaC (19.5 
nM) to a suspension of asolectin vesicles (5 μΜ) at pH values 
ranging from 7.2 to 5.0 are shown in Fig. 2. Under these assay 
conditions, the lipid/protein molar ratio was 256 and the pro-
tein/vesicle ratio was 324. The concentration of urea in the 
assay never exceeded 64 mM, a concentration which had no 
effect on stability of vesicles, regardless of the pH of the sus-
pension (data not shown). For all the pH values tested, IpaC 
induced a rapid release of calcein. In addition, the efficiency of 
release was modulated by the pH, a maximal release being 
obtained at pH 5.4 (see inset in Fig. 2). 
A characteristic of some bacterial toxins, such as diphtheria 
toxin, is that they aggregate upon incubation in conditions 
which promote their interaction with the lipid membrane. 
This aggregation leads to a decreased ability of the protein 
to destabilize the lipid vesicles [15]. To test this property, IpaC 
was diluted in order to reach a final concentration of 19.5 nM 
in buffers which did not contain urea and incubated for 1 h at 
37°C prior to addition of calcein-loaded vesicles and monitor-
ing of calcein release. As shown in Fig. 2 (curves A and E), 
preincubation of IpaC at a low concentration of urea at either 
pH 5.0 or pH 7.2 decreased the ability of the protein to induce 
calcein release, although the effect was less marked at pH 7.2 
than at pH 5.0. This suggested that, in the absence of urea, 
IpaC was partially aggregated and could no longer interact 
with the lipid membrane. 
3.3. Interaction of IpaC with the lipid membrane as a function 
of lipid composition 
Membranes of eucaryotic cells contain about 20% of nega-
tively charged lipids [21], which are also present in the same 
proportion in asolectin [15]. To investigate the role of charged 
lipids in interaction of IpaC with the lipid membrane, we used 
vesicles containing various amounts of egg phosphatidylcho-
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Fig. 2. Effect of pH on the release of calcein induced by IpaC. 
Curves a-e show kinetics of calcein release from asolectin LUV 
(5 μΜ) induced by IpaC (19.5 nM) at different pH: (a) pH 7.2; 
(b) pH 6.5; (c) pH 6.0; (d) pH 5.4; (e) pH 5.0. The arrow indicates 
the addition of the protein. For each pH value, the percentage of cal-
cein release obtained after 1 min, calculated as described in Section 
2, is shown in the inset. Curves A and E show kinetics of calcein re-
lease from asolectin LUV (5 μΜ) induced by IpaC (19.5 nM) which 
had been preincubated for 1 h at a low concentration of urea at pH 
7.2 (A) and 5.0 (E) prior to the addition of calcein-loaded vesicles. 
On these two curves, the arrow indicates the addition of vesicles. The 
fluorescence due to vesicles was subtracted from the spectra. In all 
cases, the kinetics were rescaled between 0 (F0) and 1 (ίΊ0ο). 
line (egg PC), a neutral lipid, and phosphatidylserine (PS), a 
negatively charged lipid. Fig. 3 shows that, at pH 5.0, the 
release of calcein is dependent on the concentration of nega-
tively charged lipid in the membrane, virtually no calcein re-
lease being observed with the neutral vesicles (Fig. 3) even at 
concentrations of IpaC up to 146 nM (data not shown). A 
similar effect was observed at pH 7.2 (data not shown), sug-
gesting that, at both pH, an electrostatic component was in-
volved in the interaction of IpaC with a lipid membrane. 
3.4. Determination of an apparent binding constant of IpaC to 
asolectin vesicles 
To determine an apparent binding constant of IpaC to aso-
lectin vesicles, calcein release was studied as a function of 
IpaC concentration, for four different lipid concentrations 
(5, 12.5, 25 and 37.5 μΜ) at both pH 7.2 (Fig. 4A) and pH 
5.0 (Fig. 4B). As the lipid concentration was increased, a high-
er concentration of IpaC was required to release a determined 
amount of calcein, which suggested that the leakage rate was 
determined by the amount of membrane-bound protein per 
lipid molecule. This quantity, r, is related to such experimental 
parameters as the total protein concentration, Ct, the free 
protein concentration, Q, and the lipid concentration, L, 
through the equation: Ct = Q+rL (for a more detailed de-
scription of this formalism, see [22]). Plots of Ct versus L 
for different extents of release (between 15 and 50%) were 
obtained (not shown) from a plot of the percentage of calcein 
release versus Ct (Fig. 4A-B) at different L values. According 
to the mass equation, the corresponding r and Q values were 
calculated from the slope and the intercept, respectively. The 
relationships between r and Q (binding isotherm) are shown 
in Fig. 5. An apparent binding constant was evaluated by 
linearly extrapolating the curve to the zero concentration of 
free protein [23], which gave a ΚΆνν of 34 X 10
3 IVT1 at pH 7.2 
and of 410 X 103 M"1 at pH 5.0. 
4. Discussion 
Analysis of strains carrying non-polar mutations in ipaA, 
ipaB, ipaC, and ipaD has indicated that each of the Ipa pro-
teins, but IpaA, was required to induce entry into epithelial 
[12], and also to lyse the membrane of the phagocytic vacuole 
when these strains were internalized by macrophages [13]. 
Moreover, a complex containing IpaB, IpaC, and IpaA, but 
not IpaD, has been detected in the culture medium of Shigella 
[8] and it has been demonstrated recently that this complex 
was able to promote uptake of inert particles by epithelial 
cells [9]. These data suggested that IpaB and IpaC proteins, 
either individually or as a complex, might interact with the 
cell membrane. Here, we have reported the purification to 
homogeneity of IpaC and the characterization of the interac-
tion of the purified protein with lipid membranes as a function 
of pH and lipid composition of the membrane. 
IpaC has been purified from the culture medium of an ipaB 
sepA mutant, which rules out any possible contamination by 
IpaB. The purification scheme involves only an ammonium 
sulfate precipitation and a single chromatography step (anion 
exchange). The purification had to be carried out in the pres-
ence of urea, since, in the absence of urea, IpaC was most 
probably aggregated. Indeed, preincubation of IpaC in a buf-
fer containing only a low concentration of urea reduced the 
ability of the protein to induce calcein release. Some virulence 
factors known for their ability to interact with a lipid mem-
brane, such as the Escherichia coli hemolysin, require a con-
centration of up to 6 M urea to be maintained in solution [24]. 
The ability of diphtheria (DT) and anthrax (PA, LF, and 
EF) toxins to interact with the cell membrane and to reach the 
cell cytoplasm is pH-dependent [25-27], a phenomenon which 
has also been observed for interaction of these toxins with 
artificial lipid membranes [11,15]. The amount of IpaC re-
quired to induce 50% release of calcein from asolectin large 
=s 0 'l· 200 400 600 800 
Time (sec) 
Fig. 3. Effect of negatively charged lipids on the release of calcein 
induced by IpaC. Kinetics of calcein release from LUV made of egg 
PC and of mixtures of egg PC and PS are shown: (a) egg PC; 
(b) egg PC/PS (9:1, w/w); (c) egg PC/PS (8:2, w/w). The arrow indi-
cates the addition of the protein. Kinetics were rescaled between 0 
(F0) and 1 (Fm). 
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unilamellar vesicles at low p H is in the same range as that of 
these toxins (LF and E F : 3.5 n M [11] and D T B fragment: 
250 n M [15]) which have been demonstrated to insert into and 
to translocate across a cell membrane. These comparisons 
strongly suggest that IpaC might interact with the cell mem-
brane. 
We have determined apparent binding constants of IpaC to 
lipid vesicles at neutral and low pH. However, these values 
were obtained by measuring the efficiency of IpaC to destabi-
lize a lipid membrane. Therefore, the 10 times difference ob-
served between the two p H values could result from two dif-
ferent and non-exclusive mechanisms, either an increase of the 
amount of protein bound to the lipids or an increase of the 
efficiency of the bound protein in destabilizing the membrane. 
A pH-driven multimerization process, for example, would be 
a way to increase the efficiency of calcein release without any 
increase of the amount of bound protein. Nonetheless, the 
different behaviours we are observing at neutral and low pH 
might be relevant to the dual role of Ipa proteins in inducing 
membrane ruffles upon entry and lysis of the endosome mem-
brane thereafter. When secretion is activated close to the eu-
karyotic cell membrane, the resulting high local concentration 
of Ipa proteins might be sufficient to allow a certain propor-
tion of IpaC, or of a complex containing IpaC, to interact 
with the membrane. This would be sufficient to induce entry. 
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Fig. 4. Effect of IpaC and lipid concentrations on the release of cal-
cein. Percentages of calcein released from asolectin LUV were deter-
mined at various concentrations of IpaC and lipids at pH 7.2 (A) 
and pH 5.0 (B). Lipid concentration: o . 5 μΜ; v , 12.5 μΜ; Δ, 
25.0 μΜ; D, 37.5 μΜ. 
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Fig. 5. Evaluation of the apparent binding constant of IpaC to aso-
lectin LUV. Binding isotherms, calculated from Fig. 4 as described 
in the text, are shown for two values: G, pH 7.2; o . pH 5.0. 
Once the bacterium has been internalized within a vacuole, an 
increase in the amount of membrane-bound Ipa proteins or an 
increased efficiency of the interaction of these proteins with 
the membrane might be responsible for the disruption of the 
endosome membrane. The p H of the Shigella-induced vacuole 
is not known, but it has been proposed recently that the p H of 
the vacuole in which Salmonella reside after entry into epithe-
lial cells is acidic [28]. This suggests that the p H effect we 
observed for binding of IpaC to lipids might be a physiologi-
cally related process. 
Interaction of IpaC with the lipid membrane requires the 
presence of negatively charged lipids in the membrane. In-
deed, calcein release was not observed from egg P C vesicles 
even at a high concentration of IpaC (146 nM) , and addition 
of negatively charged lipids in the membrane of egg PC vesi-
cles allowed us to show that the IpaC-induced calcein release 
was dependent on the concentration of negatively charged 
lipids in the membrane. The effect of acidic lipids on the 
activity of IpaC could be due to a direct interaction of IpaC 
with the negative charges at the surface of the vesicles or to a 
lower p H at the surface of a membrane containing negatively 
charged lipids. We can rule out the latter hypothesis since 
asolectin vesicles contain about 20% of negatively charged 
lipids which generate a surface p H that would be about 0.5 
unit lower than the p H of the suspension [15]. If solely the 
surface p H was involved in the interaction of IpaC with the 
lipid membrane, a similar efficiency would be observed for 
binding of the protein to asolectin and egg P C vesicles, except 
that the two curves would be shifted of a value of 0.5-1 p H 
unit, as previously observed with diphtheria toxin [15]. There-
fore, the dependence of IpaC-induced calcein release on the 
presence of negatively charged lipids suggests that negative 
charges are essential for the protein either to bind at the 
vesicle surface or to induce a conformational change which 
would allow insertion of the protein in the lipid membrane. 
Characterization of secondary and tertiary structures of IpaC 
as a function of the p H and the presence of negatively charged 
vesicles is under investigation using Fourier transform infra-
red spectroscopy. 
Interaction of several virulence factors with the cell mem-
brane results in the formation of a channel in the membrane. 
In the case of diphtheria toxin, this channel is involved in 
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translocation of the enzymatic moiety of the toxin (see [10], 
for a review), whereas, in the case of the E. coli hemolysin, the 
channel allows the transport of ions [29], which leads to an 
interference with the cell metabolism and/or to lysis of the cell 
(see [30], for a review). Although we have shown that IpaC 
was able to interact with a lipid membrane, preliminary ex-
periments failed to demonstrate that IpaC was forming a 
channel in a planar lipid bilayer (Dr. F . Horrible, personal 
communication), which suggests that interaction of IpaC 
with the lipid membrane of LUV does not result in channel 
formation. This does not exclude the possibility that a channel 
is formed upon interaction of Shigella with the cell surface, 
since other Ipa proteins, such as IpaB, might participate in the 
formation of such a structure. Understanding the molecular 
mechanism of action of the Shigella effectors of entry will 
require purification of each of the other Ipa proteins, as 
well as that of a well defined IpaC- IpaB complex, and char-
acterization of their interaction with the lipid membrane. 
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